Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 7/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/22

Curator: Scholastica

Revision editor(s): Scholastica

Source: Supplementary Fig. S4D

Description: Metagenomics analyses of stool samples from early breast cancer patients after chemotherapy according to axillary lymph node involvement: positive lymph node (pN+, blue dots) versus negative lymph node (pN-, orange dots)

Abundance in Group 1: increased abundance in pN+ post-Chemo

NCBI	Quality Control	Links
Alistipes onderdonkii
Anaerotignum lactatifermentans
Blautia producta
Blautia sp. CAG:257
Blautia wexlerae
Butyricicoccus pullicaecorum
Clostridium sp. CAG:678
Dorea sp. CAG:317
Eggerthella lenta
Eisenbergiella massiliensis
Enterocloster aldenensis
Enterocloster bolteae
Enterocloster bolteae CAG:59
Enterococcus durans
Eubacterium sp. CAG:38
Gordonibacter pamelaeae
Intestinibacter bartlettii
Parabacteroides merdae
Proteus mirabilis
Rothia mucilaginosa
Sellimonas intestinalis
Streptococcus mitis
Streptococcus sp. A12
Streptococcus thermophilus
Streptococcus vestibularis
Thomasclavelia ramosa
Veillonella parvula
Veillonella rogosae
Veillonella tobetsuensis
[Clostridium] leptum
[Clostridium] nexile

Revision editor(s): Scholastica